Effect of the supplement on associative memory in cognitively intact older adults - A randomized, double-blind, placebo-controlled, parallel-group clinical trial

Not Applicable

• Conditions: Cognitively intact older adults

• Registration Number: JPRN-UMIN000034059
• Lead Sponsor: FANCL Corporation

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2018-09-07
• Study Completion: 2019-05-31
• Last Update Posted: 17 October 2023

Recruitment & Eligibility

• Status: Pending
• Sex: All
• Target Recruitment: 40

Inclusion Criteria

Not provided

Exclusion Criteria

1.Smoker 2.Who is using the heart pacemaker 3.Who has records of any of the below:autonomic nervous system disease (autonomic imbalance, Meniere syndrome), brain disease, depression, bipolar depression and mood disorder 4.Who is taking medicine, Chinese medicine or supplements for brain function or brain blood flow improvement. 5.Who has dermatosis on head. 6.Who has records of any of the below:cerebral hemorrhage, subarachnoid hemorrhage, cardiac hypertrophy, cardiac decompensation, ischemic heart disease, nephrosclerosis, Aortic dissection, brain infarction. 7.Who had brain damage and hospitalized or had an operation within the past 10 years. 8.High blood pressure, hyperlipidemia, diabetes, hepatopathy, kidney disease, malignant tumor. 9.Who is participating other study.

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
-Hemoglobin oxygenation state in the brain -Behavioral data (accuracy, error rate, response time)

Secondary Outcome Measures

Name	Time	Method
-Attentional task score (1) -Attentional task score (2) -Questionnaire score